Malignant tumors of the larynx: Clinicopathologic profile and implication for late disease presentation

Ayotunde James Fasunla, Oluwole Agboola Ogundoyin, Paul Adekunle Onakoya, Onyekwere George Nwaorgu, Ayotunde James Fasunla, Oluwole Agboola Ogundoyin, Paul Adekunle Onakoya, Onyekwere George Nwaorgu

Abstract

Background: Malignant laryngeal tumors are uncommon. Late presentation of the disease may worsen management outcomes. We described the epidemiologic, clinicopathologic profile, and management outcomes of laryngeal tumors in a tertiary health institution in Nigeria.

Materials and methods: An 11-year retrospective review of medical records of patients managed for malignant laryngeal tumor at the University College Hospital, Ibadan, Nigeria, was performed.

Results: There were 97 patients comprising 74 (76.3%) males and 23 (23.7%) females with a mean age of 60.48 ± 12.15 years. The mean duration of illness was 7.3 ± 3.8 months. History of cigarette smoking and alcohol consumption was in 2.1% and 14.4% patients, respectively. The most common clinical presentations were hoarseness, cough, and dyspnea. Transglottis (91.8%) was the most common anatomic tumor location and 92.8% patients presented in advanced disease stage. Four histologic types were identified with squamous cell carcinoma accounting for 96.9%. About 92% patients had emergency tracheostomy and 56 (57.7%) patients had total laryngectomy. The postoperative complications were pharyngocutaneous fistula (5.2%) and peristomal recurrence (3.1%). The 5-year survival rate was 52.5%.

Conclusions: Malignant laryngeal tumors are uncommon, but more females are getting the disease. Squamous cell carcinoma is the most common histologic variant. Late stage disease presentation and initial wrong diagnosis contributed to the poor management outcome.

Keywords: Late disease presentation; malignant laryngeal tumor; peristomal recurrence; pharyngocutaneous fistula; tracheostomy.

Figures

Figure 1
Figure 1
Cases of laryngeal malignant tumor per year

References

    1. Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A, et al. Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501) Head Neck. 2005;27:843–50.
    1. Barnes L, Eveson JW, Reichart P, Sidransky D. World Health Organization Classification of Tumours: Pathology and Genetics of Head and Neck Tumours. Lyon: IARC Press; 2005.
    1. Canova C, Richiardi L, Merletti F, Pentenero M, Gervasio C, Tanturri G, et al. Alcohol, tobacco and genetic susceptibility in relation to cancers of the upper aerodigestive tract in northern Italy. Tumori. 2010;96:1–10.
    1. Elwood JM, Pearson JC, Skippen DH, Jackson SM. Alcohol, smoking, social and occupational factors in the aetiology of cancer of the oral cavity, pharynx and larynx. Int J Cancer. 1984;34:603–12.
    1. Duray A, Descamps G, Arafa M, Decaestecker C, Remmelink M, Sirtaine N, et al. High incidence of high-risk HPV in benign and malignant lesions of the larynx. Int J Oncol. 2011;39:51–9.
    1. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92:709–20.
    1. Morshed K. Association between human papillomavirus infection and laryngeal squamous cell carcinoma. J Med Virol. 2010;82:1017–23.
    1. Qadeer MA, Colabianchi N, Strome M, Vaezi MF. Gastroesophageal reflux and laryngeal cancer: Causation or association? A critical review. Am J Otolaryngol. 2006;27:119–28.
    1. El-Serag HB, Hepworth EJ, Lee P, Sonnenberg A. Gastroesophageal reflux disease is a risk factor for laryngeal and pharyngeal cancer. Am J Gastroenterol. 2001;96:2013–8.
    1. Goodman M, Morgan RW, Ray R, Malloy CD, Zhao K. Cancer in asbestos-exposed occupational cohorts: A meta-analysis. Cancer Causes Control. 1999;10:453–65.
    1. Wight R, Paleri V, Arullendran P. Current theories for the development of nonsmoking and nondrinking laryngeal carcinoma. Curr Opin Otolaryngol Head Neck Surg. 2003;11:73–7.
    1. Boeing H, Dietrich T, Hoffmann K, Pischon T, Ferrari P, Lahmann PH, et al. Intake of fruits and vegetables and risk of cancer of the upper aero-digestive tract: The prospective EPIC-study. Cancer Causes Control. 2006;17:957–69.
    1. Meyskens FL, Jr, Szabo E. Diet and cancer: The disconnect between epidemiology and randomized clinical trials. Cancer Epidemiol Biomarkers Prev. 2005;14:1366–9.
    1. Robin PE, Reid A, Powell DJ, McConkey CC. The incidence of cancer of the larynx. Clin Otolaryngol Allied Sci. 1991;16:198–201.
    1. Braakhuis BJ, Leemans CR, Visser O. Incidence and survival trends of head and neck squamous cell carcinoma in the Netherlands between 1989 and 2011. Oral Oncol. 2014;50:670–5.
    1. Dias FL, Lima RA, Manfro G, Barbosa MM, Salviano S, Rocha RM, et al. Management of the N0 neck in moderately advanced squamous carcinoma of the larynx. Otolaryngol Head Neck Surg. 2009;141:59–65.
    1. Rodrigo JP, Cabanillas R, Franco V, Suárez C. Efficacy of routine bilateral neck dissection in the management of the N0 neck in T1-T2 unilateral supraglottic cancer. Head Neck. 2006;28:534–9.
    1. Somefun OA, Nwawolo CC, Okeowo PA, Alabi SB, Abdul-Kareem FB, Banjo AA, et al. Prognostic factors in the management outcome of carcinoma of the larynx in Lagos. Niger Postgrad Med J. 2003;10:103–6.
    1. Nwaorgu OG, Onakoya PA, Usman MA, Abdu A. Laryngeal carcinoma: Clinical features seen at University College Hospital, Ibadan. Trop Doct. 2002;32:236–7.
    1. Greisen O, Carl J, Pedersen M. A consecutive series of patients with laryngeal carcinoma treated by primary irradiation. Acta Oncol. 1997;36:279–82.
    1. Amusa YB, Badmus A, Olabanji JK, Oyebamiji EO. Laryngeal carcinoma: Experience in Ile-Ife, Nigeria. Niger J Clin Pract. 2011;14:74–8.
    1. Straif K, Baan R, Grosse Y, Secretan B, El Ghissassi F, Cogliano V. WHO International Agency for Research on Cancer Monograph Working Group. Carcinogenicity of household solid fuel combustion and of high-temperature frying. Lancet Oncol. 2006;7:977–8.
    1. Sapkota A, Gajalakshmi V, Jetly DH, Roychowdhury S, Dikshit RP, Brennan P, et al. Indoor air pollution from solid fuels and risk of hypopharyngeal/laryngeal and lung cancers: A multicentric case-control study from India. Int J Epidemiol. 2008;37:321–8.
    1. Llewellyn CD, Linklater K, Bell J, Johnson NW, Warnakulasuriya KA. Squamous cell carcinoma of the oral cavity in patients aged 45 years and under: A descriptive analysis of 116 cases diagnosed in the South East of England from 1990 to 1997. Oral Oncol. 2003;39:106–14.
    1. Marchioni DL, Fisberg RM, do Rosário M, Latorre DO, Wunsch V. Diet and cancer of oral cavity and pharynx: A case-control study in São Paulo, Brazil. IARC Sci Publ. 2002;156:559–61.
    1. Fasunla AJ, Ogunkeyede SA. Factors contributing to poor management outcome of sinonasal malignancies in South-west Nigeria. Ghana Med J. 2013;47:10–5.
    1. Onakoya PA, Nwaorgu OG, Kokong DD, Adeosun AA, Ayodele KJ. Stomal recurrence post laryngectomy in University College Hospital, Ibadan. Afr J Med Med Sci. 2004;33:65–8.
    1. Fagan JJ, Loock JW. Tracheostomy and peristomal recurrence. Clin Otolaryngol Allied Sci. 1996;21:328–30.
    1. Esteller E, Agüero A, Martel M, López M, Quer M, León X. Stomal recurrence in head and neck cancer patients with temporary tracheostomy. Auris Nasus Larynx. 2014;41:467–70.
    1. Virtaniemi JA, Kumpulainen EJ, Hirvikoski PP, Johansson RT, Kosma VM. The incidence and etiology of postlaryngectomy pharyngocutaneous fistulae. Head Neck. 2001;23:29–33.
    1. Daniel A, Fasunla AJ, Elumelu TN, Nwaorgu OG. Comparative analysis of serum zinc and Vitamin A in patients with head and neck squamous cell carcinoma and healthy individuals. Br J Med Med Res. 2016;11:1–9.
    1. Bain LE, Awah PK, Geraldine N, Kindong NP, Sigal Y, Bernard N, et al. Malnutrition in Sub-Saharan Africa: Burden, causes and prospects. Pan Afr Med J. 2013;15:120.
    1. Liu CY, Wang MC, Li WY, Chang SY, Chu PY. Sarcoma of the larynx: Treatment results and literature review. J Chin Med Assoc. 2006;69:120–4.
    1. Dei Tos AP, Dal Cin P, Sciot R, Furlanetto A, Da Mosto MC, Giannini C, et al. Synovial sarcoma of the larynx and hypopharynx. Ann Otol Rhinol Laryngol. 1998;107:1080–5.
    1. Al-Nemer A, El-Shawarby MA. Laryngeal synovial sarcoma: Case report and literature review. Gulf J Oncolog. 2011;9:52–6.
    1. Thompson LD, Gannon FH. Chondrosarcoma of the larynx: A clinicopathologic study of 111 cases with a review of the literature. Am J Surg Pathol. 2002;26:836–51.
    1. Tiwari R, Mahieu H, Snow G. Long-term results of organ preservation in chondrosarcoma of the cricoid. Eur Arch Otorhinolaryngol. 1999;256:271–6.
    1. Oliveira JF, Branquinho FA, Monteiro AR, Portugal ME, Guimarães AM. Laryngeal chondrosarcoma – Ten years of experience. Braz J Otorhinolaryngol. 2014;80:354–8.
    1. Marchiano E, Chin OY, Fang CH, Park RC, Baredes S, Eloy JA. Laryngeal adenoid cystic carcinoma: A systematic review. Otolaryngol Head Neck Surg. 2016;154:433–9.
    1. Nielsen TK, Bjørndal K, Krogdahl A, Primdahl H, Kristensen CA, Andersen E, et al. Salivary gland carcinomas of the larynx: A national study in Denmark. Auris Nasus Larynx. 2012;39:611–4.
    1. Ganly I, Patel SG, Coleman M, Ghossein R, Carlson D, Shah JP. Malignant minor salivary gland tumors of the larynx. Arch Otolaryngol Head Neck Surg. 2006;132:767–70.
    1. Liu W, Chen X. Adenoid cystic carcinoma of the larynx: A report of six cases with review of the literature. Acta Otolaryngol. 2015;135:489–93.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere